Discover how our integrated approach to analysing world Healthcare markets gives you the insight you need to inform critical decisions.


Pharmaceuticals & Healthcare Outlook For 2018: Central & Eastern Europe

Drugmakers in Central and Eastern Europe will continue to benefit from the region's high pharmaceutical market growth potential although widespread public healthcare funding issues may restrict revenue growth. In 2018, a number of governments will seek to address these issues through the transformation of healthcare systems while pharmaceutical regulatory harmonisation will provide additional means to improve cost efficiency. Drugmakers must remain conscious of these developments in order to circumnavigate administrative hurdles to maximise revenue generation.





Sakshi Sikka

Pharmaceuticals and Healthcare Analyst
Pharmaceuticals & Healthcare | Singapore

Craig Smith

Pharmaceuticals & Healthcare Analyst
Pharmaceuticals & Healthcare | London

Peter Elphick

Pharmaceuticals & Healthcare Analyst
Pharmaceuticals & Healthcare | London

Kaushal Shah

Head of Pharmaceuticals and Healthcare Research
Pharmaceuticals & Healthcare | London


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.